| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |